Mohit Kehar

Investigator, CHEO Research Institute

Dr. Kehar has joined the Division of Pediatric Gastroenterology, Hepatology, and Nutrition as a staff physician on November 1st, 2020. Dr. Kehar was born in India where he completed his pediatrics and pediatric gastroenterology training. He completed his Pediatric Gastroenterology, Hepatology and Nutrition Fellowship at Hospital for Sick Children and worked as locum staff. He moved to Queens University in 2018 as an Assistant Professor and was the clinical lead of the section of Pediatric Gastroenterology before moving to CHEO.

Research interests: Pediatric non-alcoholic fatty liver disease, Pediatric Hepatology

Research areas: Hepatology, Gastroenterology

Research Projects

  1. Priority actions for elevating liver health in Canada: A call to action


    Chronic liver disease and its complications impart tremendous patient and health system burdens that are largely preventable in Canada. In addition to crystallized efforts to eliminate viral hepatitis, prevention and early case-finding of patients at risk of ALD and NAFLD along with fibrosis detection offer opportunities to interrupt the disease process and extend survival. National policy and organizational support of care teams will be critical to the successful control of this silent epidemic in Canada.

  2. Impact of decompensated cirrhosis in children: A population-based study


    To improve the care of children with liver disease, early detection of liver disease, early initiation of specific treatments as well as identification of children who are at risk of becoming decompensated are crucial.

  3. Screening Patterns of Nonalcoholic Fatty Liver Disease in Children with Obesity in Canadian Primary Care: A Cross-Sectional Study


    In our study, we examined the proportion of childhood NAFLD screening in a large national multicenter database and identified very low screening rates (8.7% in the past year and 23.6% ever screened). Among the children with suspected NAFLD, many had associated comorbidities, including depression, hypertension, and dyslipidemia. As a result of its silent nature, it is likely that patients with NASH cirrhosis may develop the disease as youths and remain undiagnosed until they have reached adulthood [25], highlighting the importance of early detection and intervention. There is a critical need for PCPs and pediatric specialists to work together toward establishing a clinical referral pathway to address the identified gaps in screening and management of pediatric NAFLD in Canadian primary care.

  4. Awareness, management, and practice patterns of pediatric NAFLD by primary care physicians


    Dissemination and implementation of clinical guidelines have the potential to improve knowledge and screening rates for NAFLD in children at the primary-care level.

  5. North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition Position Paper on the Diagnosis and Management of Pediatric Acute Liver Failure


    we will provide clinical guidance to pediatric gastroenterologists and other pediatric providers caring for children with PALF by presenting the most recent advances in diagnosis, management, pathophysiology, and associated outcomes.